佳電股份(000922.SZ):子公司擬投建主氦風機成套產業化項目
格隆匯11月19日丨佳電股份(000922.SZ)公佈,為緊跟國家重點推廣第四代核電技術趨勢,增強主氦風機產業成套批量生產及試驗能力,拓展核電領域發展,增強公司核心競爭力,公司子公司佳木斯電機股份有限公司(“佳電公司”)擬投資27299萬元建設主氦風機成套產業化項目。
該項目的效益測算是根據目前的市場狀況及成本費用水平進行的估算,項目實施並達到設計規模後,可形成年產主氦風機產品6套、高壓防爆和普通電機570台的生產能力。每年可實現銷售收入(不含税)36000萬元,利潤總額6300萬元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.